RSKD - Riskified Ltd.

QQQ $ 451.63 $ -0.22 (-0.05 %)

DIA $ 399.76 $ 0.74 (0.19 %)

SPY $ 529.24 $ 0.76 (0.14 %)

TLT $ 91.40 $ -0.62 (-0.67 %)

GLD $ 223.63 $ 3.63 (1.65 %)

Previous Close

$ 5.97

Open

$ 5.58

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 5.58 - $ 5.98

52 Week Range

$ 3.48 - $ 6.29

Volume

1,560,449

Average Volume

Market Cap

2.11B

Beta (5Y Monthly)

$ 1.59

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

DA Davidson Maintains Neutral on Riskified...
05/16/2024 16:16:06

DA Davidson analyst Gil Luria maintains Riskified (NYSE:RSKD) with a Neutral and raises the price target from $5 to $7.

Keefe, Bruyette & Woods Maintains Market P...
05/16/2024 12:44:54

Keefe, Bruyette & Woods analyst Ryan Tomasello maintains Riskified (NYSE:RSKD) with a Market Perform and raises the pric...

riskified-analysts-boost-their-forecasts-after-strong-q1-results

Riskified Analysts Boost Their Forecasts A...
05/16/2024 12:41:06

JP Morgan Maintains Neutral on Riskified, ...
05/16/2024 12:31:31

JP Morgan analyst Reginald Smith maintains Riskified (NYSE:RSKD) with a Neutral and raises the price target from $6 to $7.

Truist Securities Reiterates Buy on Riskif...
05/16/2024 12:20:09

Truist Securities analyst Terry Tillman reiterates Riskified (NYSE:RSKD) with a Buy and raises the price target from $7.5 to...

What Analysts Are Saying About Riskified S...
05/16/2024 12:00:26

Piper Sandler Maintains Overweight on Risk...
05/16/2024 10:51:43

Piper Sandler analyst Clarke Jeffries maintains Riskified (NYSE:RSKD) with a Overweight and raises the price target from $7 ...

why-bolt-biotherapeutics-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Bolt Biotherapeutics Shares Are Tradin...
05/15/2024 17:38:38

12-information-technology-stocks-moving-in-wednesdays-intraday-session

12 Information Technology Stocks Moving In...
05/15/2024 16:31:48

nextracker-posts-upbeat-earnings-joins-mondaycom-nu-holdings-and-other-big-stocks-moving-higher-on-wednesday

NEXTracker Posts Upbeat Earnings, Joins mo...
05/15/2024 14:21:59

Riskified Authorized Repurchase Of An Addi...
05/15/2024 11:11:50

Riskified Reiterates FY24 Revenue Outlook ...
05/15/2024 11:08:56

Financial Outlook: For the year ending December 31, 2024, we continue to expect: Revenue between $323 million and $335 mill...

Riskified Q1 Adj $0.04 Beats $0.02 Estimat...
05/15/2024 11:03:51

Riskified (NYSE:RSKD) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 100 ...

Piper Sandler Reiterates Overweight on Ris...
04/12/2024 10:03:45

Piper Sandler analyst Clarke Jeffries reiterates Riskified (NYSE:RSKD) with a Overweight and maintains $7 price target.

Where Riskified Stands With Analysts
04/09/2024 12:01:03

Keefe, Bruyette & Woods Initiates Coverage...
04/09/2024 10:29:25

Keefe, Bruyette & Woods analyst Ryan Tomasello initiates coverage on Riskified (NYSE:RSKD) with a Market Perform rating ...

12-information-technology-stocks-moving-in-thursdays-after-market-session

12 Information Technology Stocks Moving In...
03/28/2024 20:31:05

A Closer Look at 4 Analyst Recommendations...
03/06/2024 19:00:34

DA Davidson Reiterates Neutral on Riskifie...
03/06/2024 18:48:12

DA Davidson analyst Gil Luria reiterates Riskified (NYSE:RSKD) with a Neutral and maintains $5 price target.

Goldman Sachs Maintains Neutral on Riskifi...
03/06/2024 16:38:26

Goldman Sachs analyst Will Nance maintains Riskified (NYSE:RSKD) with a Neutral and raises the price target from $4.5 to $5.